Riluzole Oral Soluble Film (ROSF) Swallowing Safety in Amyotrophic Lateral Sclerosis (ALS)
Clinical trial NCT03679975 · TERMINATED
Trial details
- NCT number
- NCT03679975
- Sponsor
- Aquestive Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-04
- Primary completion
- 2018-09-26
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.